API reference

Roxadustat

CAS number
808118-40-3
Molecular formula
C19H16N2O5
Molecular weight
352.3 g/mol
Roxadustat — 2D structure
2D structure (PubChem)

About this molecule

Roxadustat is an orally bioavailable, hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), with potential anti-anemic activity. Upon administration, roxadustat binds to and inhibits HIF-PHI, an enzyme responsible for the degradation of transcription factors in the HIF family under normal oxygen conditions. This prevents HIF breakdown and promotes HIF activity. Increased HIF activity leads to an increase in endogenous erythropoietin production, thereby enhancing erythropoiesis. It also reduces the expression of the peptide hormone hepcidin, improves iron availability, and boosts hemoglobin (Hb) levels. HIF regulates the expression of genes in response to reduced oxygen levels, including genes required for erythropoiesis and iron metabolism.

Source: NCI Thesaurus (NCIt), via PubChem.

Identifiers

IUPAC name
2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid
InChIKey
YOZBGTLTNGAVFU-UHFFFAOYSA-N
SMILES
CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3
PubChem CID
11256664

Also known as

Roxadustat · Evrenzo · roxadustatum · B03XA05 · 8HO · Evrenzo (TN) · Roxadustat (Standard) · (4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)glycine

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com